Exact Sciences UK, Ltd.
- Home
- Companies
- Exact Sciences UK, Ltd.
- Products
- Oncotype - Model DX - Genomic Tests and ...
Oncotype - Model DX - Genomic Tests and Services Portfolio
Every cancer is unique and affects each diagnosed person differently based on the individual biology of his or her disease. To address this diversity and make cancer care smarter at every stage, our Oncotype DX genomic tests and services portfolio delivers clinically relevant genomic intelligence that reveals the individual biology of a patient`s tumour.
Most popular related searches
genomic test
genomic tested
genomic testing
genomics
prostate cancer
cancer patient
surgery
colon
prostate
chemotherapy
This additional genomic insight helps clinicians optimise treatment decisions for breast, colon, and prostate cancers by answering questions such as:
- Do I need chemotherapy?
- Do I have an aggressive form of cancer?
- Do I need surgery?
- Will I need additional treatment after surgery?
The Oncotype DX tests have been used to guide treatment decisions for more than 1 million cancer patients worldwide.